Documents

Record production and NYSE uplisting position the company for growth amid regulatory shifts.

Q1 results missed margin targets, but 2026 guidance remains strong with major export potential.

2026 outlook projects robust revenue and margin recovery, driven by expanded cultivation and new markets.

Revenue and margins fell sharply in Q3, but 2026 is set for record production and growth.

Q2 saw record results and retail outperformance, but labor issues will weigh on Q3 before a Q4 rebound.

Q1 revenue up 49% year-over-year, with strong retail and margin gains despite market headwinds.

Record 2024 growth, cost leadership, and hemp strategy position for strong 2025 performance.

Record Q3 revenue and production, strong margins, and expansion plans despite market headwinds.

Raised production guidance, targeting $100/lb costs, and preparing for national expansion.

Record Q2 revenue and production, but FY guidance lowered amid ongoing price pressure.

Greenhouse 5’s ramp underpins record Q2 revenue guidance despite Q1 margin pressure.

Record FY23 growth and Greenhouse 5 expansion set up FY24, despite near-term startup and market pressures.